FHIR © HL7.org  |  Server Home  |  FHIR Server FHIR Server 3.7.13  |  FHIR Version n/a  User: [n/a]

900000000000508004: Great Britain English language reference set (foundation metadata concept)


Status: current, Not sufficiently defined by necessary conditions definition status (core metadata concept). Date: 31-Jan 2002. Module: SNOMED CT model component module (core metadata concept)

Descriptions:

Id Description Lang Type Status Case? Module
900000000001112010 Great Britain English language reference set en Synonym (core metadata concept) Active Entire term case sensitive (core metadata concept) SNOMED CT model component module (core metadata concept)
900000000001113017 GB English en Synonym (core metadata concept) Active Entire term case sensitive (core metadata concept) SNOMED CT model component module (core metadata concept)
900000000001114011 Great Britain English language reference set (foundation metadata concept) en Fully specified name Active Entire term case sensitive (core metadata concept) SNOMED CT model component module (core metadata concept)


1290063 members. Search Members:

Expanded Value Set


Outbound Relationships Type Target Active Characteristic Refinability Group Values
GB English Is a English [International Organization for Standardization 639-1 code en] language reference set (foundation metadata concept) true Inferred relationship Some

Members acceptabilityId
pT1: Tumour 2 cm or less in greatest dimension (anal canal) Preferred (foundation metadata concept)
pT1: Tumour 2 cm or less in greatest dimension (breast) Preferred (foundation metadata concept)
pT1: Tumour 2 cm or less in greatest dimension (carcinoma of skin excluding eyelid, vulva, penis, and melanomas) Preferred (foundation metadata concept)
pT1: Tumour 2 cm or less in greatest dimension (lip and oral cavity) Preferred (foundation metadata concept)
pT1: Tumour 2 cm or less in greatest dimension (oropharynx) Preferred (foundation metadata concept)
pT1: Tumour 2 cm or less in greatest dimension limited to the thyroid (thyroid) Preferred (foundation metadata concept)
pT1: Tumour 2 cm or less in greatest dimension without extraparenchymal extension (major salivary glands) Preferred (foundation metadata concept)
pT1: Tumour 3 cm or less in greatest dimension, surrounded by lung or visceral pleura, without bronchoscopic evidence of invasion more proximal than the lobar bronchus (i.e., not in the main bronchus) (lung) Preferred (foundation metadata concept)
pT1: Tumour 5 cm or less in greatest dimension (extraosseous primitive neuroectodermal tumour/Ewing sarcoma) Acceptable (foundation metadata concept)
pT1: Tumour 5 cm or less in greatest dimension (extraosseous primitive neuroectodermal tumour/Ewing's sarcoma) Preferred (foundation metadata concept)
pT1: Tumour 7 cm or less in greatest dimension, limited to the kidney (kidney) Preferred (foundation metadata concept)
pT1: Tumour 8 cm or less in greatest dimension (bone) Preferred (foundation metadata concept)
pT1: Tumour 8 cm or less in greatest dimension (osseous primitive neuroectodermal tumour/Ewing sarcoma) Acceptable (foundation metadata concept)
pT1: Tumour 8 cm or less in greatest dimension (osseous primitive neuroectodermal tumour/Ewing's sarcoma) Preferred (foundation metadata concept)
pT1: Tumour <= 2 cm in greatest dimension (breast) Acceptable (foundation metadata concept)
pT1: Tumour confined to the bile duct histologically (extrahepatic bile ducts) Preferred (foundation metadata concept)
pT1: Tumour confined to the nasopharynx (nasopharynx) Preferred (foundation metadata concept)
pT1: Tumour confined to the retina, vitreous, or subretinal space. No optic nerve or choroidal invasion (retinoblastoma) Preferred (foundation metadata concept)
pT1: Tumour invades lamina propria or muscle layer (gallbladder) Preferred (foundation metadata concept)
pT1: Tumour invades lamina propria or submucosa (oesophagus) Preferred (foundation metadata concept)
pT1: Tumour invades lamina propria or submucosa (small intestine) Preferred (foundation metadata concept)
pT1: Tumour invades lamina propria or submucosa (stomach) Preferred (foundation metadata concept)
pT1: Tumour invades subepithelial connective tissue (urinary bladder, ureter, renal pelvis) Preferred (foundation metadata concept)
pT1: Tumour invades submucosa (appendix) Preferred (foundation metadata concept)
pT1: Tumour invades submucosa (colon/rectum) Preferred (foundation metadata concept)
pT1: Tumour involves ipsilateral parietal pleura, with or without focal involvement of visceral pleura (thoracic mesothelioma) Preferred (foundation metadata concept)
pT1: Tumour limited to ampulla of Vater or sphincter of Oddi (ampulla of Vater) Preferred (foundation metadata concept)
pT1: Tumour limited to one subsite of hypopharynx and 2 cm or less in greatest dimension (hypopharynx) Preferred (foundation metadata concept)
pT1: Tumour limited to one subsite of supraglottis with normal vocal cord mobility (larynx, supraglottis) Preferred (foundation metadata concept)
pT1: Tumour limited to the iris (iris) (uveal melanoma) Preferred (foundation metadata concept)
pT1: Tumour limited to the maxillary sinus mucosa with no erosion or destruction of bone (maxillary sinus) Preferred (foundation metadata concept)
pT1: Tumour limited to the pancreas, 2 cm or less in greatest dimension (exocrine pancreas) Preferred (foundation metadata concept)
pT1: Tumour limited to the subglottis (larynx, subglottis) Preferred (foundation metadata concept)
pT1: Tumour limited to the testis and epididymis without vascular/lymphatic invasion; tumour may invade into the tunica albuginea but not the tunica vaginalis (testis) Preferred (foundation metadata concept)
pT1: Tumour limited to the vocal cord(s) (may involve anterior or posterior commissure) with normal mobility (larynx, glottis) Preferred (foundation metadata concept)
pT1: Tumour restricted to any one subsite, with or without bony invasion (nasal cavity and ethmoid sinus) Preferred (foundation metadata concept)
pT1a Preferred (foundation metadata concept)
pT1a (IA): Invasive carcinoma diagnosed only by microscopy. All macroscopically visible lesions (even with superficial invasion) are pT1b/IB (TNM category and FIGO stage) (uterine cervix) Preferred (foundation metadata concept)
pT1a (IA): Invasive carcinoma diagnosed only by microscopy. All macroscopically visible lesions (even with superficial invasion) are pT1b/IB (TNM category and FIGO stage) (uterine cervix) (finding) Preferred (foundation metadata concept)
pT1a (IA): Tumor confined to the vulva or vulva and perineum, 2 cm or less in greatest dimension, and with stromal invasion no greater than 1 mm (TNM category and FIGO stage) (vulva) (finding) Preferred (foundation metadata concept)
pT1a (IA): Tumor limited to endometrium (TNM category and FIGO stage) (corpus uteri) (finding) Preferred (foundation metadata concept)
pT1a (IA): Tumor limited to one fallopian tube, without penetrating the serosal surface; no ascites (TNM category and FIGO stage) (fallopian tube) (finding) Preferred (foundation metadata concept)
pT1a (IA): Tumor limited to one ovary; capsule intact, no tumor on ovarian surface. No malignant cells in ascites or peritoneal washings (TNM category and FIGO stage) (ovary) (finding) Preferred (foundation metadata concept)
pT1a (IA): Tumour confined to the vulva or vulva and perineum, 2 cm or less in greatest dimension, and with stromal invasion no greater than 1 mm (TNM category and FIGO stage) (vulva) Preferred (foundation metadata concept)
pT1a (IA): Tumour limited to endometrium (TNM category and FIGO stage) (corpus uteri) Preferred (foundation metadata concept)
pT1a (IA): Tumour limited to one fallopian tube, without penetrating the serosal surface; no ascites (TNM category and FIGO stage) (fallopian tube) Preferred (foundation metadata concept)
pT1a (IA): Tumour limited to one ovary; capsule intact, no tumour on ovarian surface. No malignant cells in ascites or peritoneal washings (TNM category and FIGO stage) (ovary) Preferred (foundation metadata concept)
pT1a - Used with permission of the American College of Surgeons, Chicago, Illinois. The original source for this information is the AJCC Cancer Staging System (2022) https://www.facs.org/quality-programs/cancer/ajcc/cancer-staging. Preferred (foundation metadata concept)
pT1a category Preferred (foundation metadata concept)
pT1a category (finding) Preferred (foundation metadata concept)
pT1a1 Preferred (foundation metadata concept)
pT1a1 (IA1): Measured stromal invasion 3.0 mm or less in depth and 7.0 mm or less in horizontal spread (TNM category and FIGO stage) (uterine cervix) Preferred (foundation metadata concept)
pT1a1 (IA1): Measured stromal invasion 3.0 mm or less in depth and 7.0 mm or less in horizontal spread (TNM category and FIGO stage) (uterine cervix) (finding) Preferred (foundation metadata concept)
pT1a1 - Used with permission of the American College of Surgeons, Chicago, Illinois. The original source for this information is the AJCC Cancer Staging System (2022) https://www.facs.org/quality-programs/cancer/ajcc/cancer-staging. Preferred (foundation metadata concept)
pT1a1 category Preferred (foundation metadata concept)
pT1a1 category (finding) Preferred (foundation metadata concept)
pT1a2 Preferred (foundation metadata concept)
pT1a2 (IA2): Measured stromal invasion more than 3.0 mm and not more than 5.0 mm in depth and 7.0 mm or less horizontal spread (TNM category and FIGO stage) (uterine cervix) Preferred (foundation metadata concept)
pT1a2 (IA2): Measured stromal invasion more than 3.0 mm and not more than 5.0 mm in depth and 7.0 mm or less horizontal spread (TNM category and FIGO stage) (uterine cervix) (finding) Preferred (foundation metadata concept)
pT1a2 - Used with permission of the American College of Surgeons, Chicago, Illinois. The original source for this information is the AJCC Cancer Staging System (2022) https://www.facs.org/quality-programs/cancer/ajcc/cancer-staging. Preferred (foundation metadata concept)
pT1a2 category Preferred (foundation metadata concept)
pT1a2 category (finding) Preferred (foundation metadata concept)
pT1a: Melanoma 1.0 mm or less in thickness and level II or III, no ulceration (melanoma of the skin) Preferred (foundation metadata concept)
pT1a: Melanoma 1.0 mm or less in thickness and level II or III, no ulceration (melanoma of the skin) (finding) Preferred (foundation metadata concept)
pT1a: Tumor 10 mm or less in greatest diameter and 2.5 mm or less in greatest height (thickness) without microscopic extraocular extension (ciliary body and choroid) (uveal melanoma) (finding) Preferred (foundation metadata concept)
pT1a: Tumor 2 cm or less in greatest dimension, limited to dermis or 2 mm or less in thickness (carcinoma of skin excluding eyelid, vulva, penis, and melanomas) (finding) Preferred (foundation metadata concept)
pT1a: Tumor 4 cm or less in greatest dimension, limited to the kidney (kidney) (finding) Preferred (foundation metadata concept)
pT1a: Tumor 5 cm or less in greatest dimension, superficial tumor (extraosseous primitive neuroectodermal tumor/Ewing's sarcoma) (finding) Preferred (foundation metadata concept)
pT1a: Tumor 5 cm or less in greatest dimension, superficial tumor (soft tissue) (finding) Preferred (foundation metadata concept)
pT1a: Tumor invades lamina propria (esophagus) (finding) Preferred (foundation metadata concept)
pT1a: Tumor invades lamina propria (gallbladder) (finding) Preferred (foundation metadata concept)
pT1a: Tumor invades lamina propria (stomach) (finding) Preferred (foundation metadata concept)
pT1a: Tumor involves ipsilateral parietal (mediastinal, diaphragmatic) pleura. No involvement of the visceral pleura (thoracic mesothelioma) (finding) Preferred (foundation metadata concept)
pT1a: Tumor limited to one vocal cord (may involve anterior or posterior commissure) with normal mobility (larynx, glottis) (finding) Preferred (foundation metadata concept)
pT1a: Tumor limited to the iris (not more than 3 clock hours in size) (iris) (uveal melanoma) (finding) Preferred (foundation metadata concept)
pT1a: Tumor more than 0.1 cm but not more than 0.5 cm in greatest dimension (breast) (finding) Preferred (foundation metadata concept)
pT1a: Tumour 10 mm or less in greatest diameter and 2.5 mm or less in greatest height (thickness) without microscopic extraocular extension (ciliary body and choroid) (uveal melanoma) Preferred (foundation metadata concept)
pT1a: Tumour 2 cm or less in greatest dimension, limited to dermis or 2 mm or less in thickness (carcinoma of skin excluding eyelid, vulva, penis, and melanomas) Preferred (foundation metadata concept)
pT1a: Tumour 4 cm or less in greatest dimension, limited to the kidney (kidney) Preferred (foundation metadata concept)
pT1a: Tumour 5 cm or less in greatest dimension, superficial tumour (extraosseous primitive neuroectodermal tumor/Ewing sarcoma) Acceptable (foundation metadata concept)
pT1a: Tumour 5 cm or less in greatest dimension, superficial tumour (extraosseous primitive neuroectodermal tumour/Ewing's sarcoma) Preferred (foundation metadata concept)
pT1a: Tumour 5 cm or less in greatest dimension, superficial tumour (soft tissue) Preferred (foundation metadata concept)
pT1a: Tumour >0.1 cm but <= 0.5 cm in greatest dimension (breast) Acceptable (foundation metadata concept)
pT1a: Tumour invades lamina propria (gallbladder) Preferred (foundation metadata concept)
pT1a: Tumour invades lamina propria (oesophagus) Preferred (foundation metadata concept)
pT1a: Tumour invades lamina propria (stomach) Preferred (foundation metadata concept)
pT1a: Tumour involves ipsilateral parietal (mediastinal, diaphragmatic) pleura. No involvement of the visceral pleura (thoracic mesothelioma) Preferred (foundation metadata concept)
pT1a: Tumour limited to one vocal cord (may involve anterior or posterior commissure) with normal mobility (larynx, glottis) Preferred (foundation metadata concept)
pT1a: Tumour limited to the iris (not more than 3 clock hours in size) (iris) (uveal melanoma) Preferred (foundation metadata concept)
pT1a: Tumour more than 0.1 cm but not more than 0.5 cm in greatest dimension (breast) Preferred (foundation metadata concept)
pT1b Preferred (foundation metadata concept)
pT1b (IB): Clinically visible lesion confined to the cervix or microscopic lesion greater than T1a2/IA2 (TNM category and FIGO stage) (uterine cervix) Preferred (foundation metadata concept)
pT1b (IB): Clinically visible lesion confined to the cervix or microscopic lesion greater than T1a2/IA2 (TNM category and FIGO stage) (uterine cervix) (finding) Preferred (foundation metadata concept)
pT1b (IB): Tumor confined to the vulva or vulva and perineum, 2 cm or less in greatest dimension, and with stromal invasion greater than 1 mm (TNM category and FIGO stage) (vulva) (finding) Preferred (foundation metadata concept)
pT1b (IB): Tumor invades less than one-half of the myometrium (TNM category and FIGO stage) (corpus uteri) (finding) Preferred (foundation metadata concept)
pT1b (IB): Tumor limited to both ovaries; capsule intact, no tumor on ovarian surface. No malignant cells in ascites or peritoneal washings (TNM category and FIGO stage) (ovary) (finding) Preferred (foundation metadata concept)
pT1b (IB): Tumor limited to both tubes, without penetrating the serosal surface; no ascites (TNM category and FIGO stage) (fallopian tube) (finding) Preferred (foundation metadata concept)
pT1b (IB): Tumour confined to the vulva or vulva and perineum, 2 cm or less in greatest dimension, and with stromal invasion greater than 1 mm (TNM category and FIGO stage) (vulva) Preferred (foundation metadata concept)
pT1b (IB): Tumour invades less than one-half of the myometrium (TNM category and FIGO stage) (corpus uteri) Preferred (foundation metadata concept)
pT1b (IB): Tumour limited to both ovaries; capsule intact, no tumour on ovarian surface. No malignant cells in ascites or peritoneal washings (TNM category and FIGO stage) (ovary) Preferred (foundation metadata concept)
pT1b (IB): Tumour limited to both tubes, without penetrating the serosal surface; no ascites (TNM category and FIGO stage) (fallopian tube) Preferred (foundation metadata concept)

Start Previous Page 12880 of 12901 Next End


Reference Sets

Reference set descriptor

GB English

US English

Back to Start